Phagovita E (Eucalyptus) 12 Lozenges

Dosage form: Pastille

Pharmacotherapeutic group: Topical anti-inflammatory and antiseptic agent.

Composition:

Active substances: specific bacteriophages active against *Streptococcus* spp., *Staphylococcus* spp., *Enterococcus* spp., and *E. coli*; eucalyptus oil;

Excipients: menthol, isomalt, gelatin, sucrose.

Pharmacological action: Causes specific lysis of *Streptococcus* spp., *Staphylococcus* spp., *Enterococcus* spp., and *E. coli* bacteria. It exhibits anti-inflammatory, antimicrobial, antiviral, and expectorant effects.

The effect of the preparation is determined by a complex of biologically active substances: specific bacteriophages active against *Streptococcus* spp., *Staphylococcus* spp., *Enterococcus* spp., and *E. coli*, as well as a complex of biologically active substances comprising essential oils (with 80% cineole content), tannins, and organic acids.

Indication: Used in combination therapy as an adjunct.

• Inflammatory diseases of the upper respiratory tract: pharyngitis, tonsillitis, laryngitis, bronchitis;

• Inflammatory diseases of the oral cavity: stomatitis, gingivitis, post-tooth extraction condition.

Contraindication: Hypersensitivity to the components of the preparation.

Side effects: None identified.

Administration and dosage: The lozenges should be sucked slowly in the mouth.

For adults and children over 12 years of age: one pastille every 2–3 hours (no more than 6–8 pastilles per day).

For children aged 5 to 12 years: one pastille 3–4 times daily (no more than 4 pastilles per day).

The duration of the course of administration must not exceed 5 days.

Overdose: No cases of overdose have been reported.

Pregnancy and lactation: The drug may be used during pregnancy and lactation upon a doctor's recommendation.

Interaction with other medicinal products or other forms of interaction: Not studied.

Effect on the ability to drive and use machines: It does not affect the ability to drive and use machines.

Presentation: 6 pastilles per blister. Two blisters in a cardboard box, together with the instructions.

Storage instructions: Store in a dry place, protected from light, at a temperature not exceeding 20°C.

Pharmacy dispensing rule: Pharmaceutical product group III – for use without a doctor's prescription, in accordance with the instructions.

Shelf life: 18 months.

Do not use the product if the expiration date has passed or if defects are detected during visual inspection.

Developed by the George Eliava Institute of Bacteriophage, Microbiology and Virology and Neopharm LLC.

Manufactured for Eliavaneo LLC by Neopharm LLC.

Georgia. Tbilisi. 12th km of David Agmashenebeli Avenue.

Tel/Fax: +995 (032) 259-64-46, 259-57-90.